Thomas Christine E 4
4 · FEMASYS INC · Filed Jan 30, 2025
Insider Transaction Report
Form 4
FEMASYS INCFEMY
Thomas Christine E
Chief Reg & Clinical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-28+28,682→ 28,682 totalExercise: $1.05From: 2025-01-28Exp: 2035-01-28→ Common Stock (28,682 underlying) - Award
Stock Option (Right to Buy)
2025-01-28+23,600→ 23,600 totalExercise: $1.05Exp: 2035-01-28→ Common Stock (23,600 underlying) - Award
Stock Option (Right to Buy)
2025-01-28+55,090→ 55,090 totalExercise: $1.05Exp: 2035-01-28→ Common Stock (55,090 underlying)
Footnotes (2)
- [F1]The shares underlying the stock option vest equally in installments over 3 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.
- [F2]The shares underlying the stock option vest equally in installments over 4 years beginning on January 28, 2025, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.